The Hepatobiliary and Pancreatic Surgery Department at Shulan (Hangzhou) Hospital is a premier center of excellence for liver, biliary, pancreatic, and transplant surgery in China. Led by internationally recognized experts, the department offers comprehensive treatment for complex liver diseases, liver cancer, pancreatic disorders, and end-stage organ failure. Equipped with advanced surgical technologies, it performs a full range of conventional, laparoscopic, and robotic-assisted minimally invasive procedures, ensuring precise treatment and faster patient recovery.
The department is a pioneer in liver transplantation and achieved a historic milestone by performing mainland China’s first adult right-lobe living-donor liver transplant. It is also renowned for developing the internationally recognized “Hangzhou Criteria” for liver cancer transplantation, which expanded transplant eligibility while maintaining excellent long-term outcomes. This breakthrough has benefited thousands of patients and significantly influenced liver transplant practices worldwide.
With more than 4,000 liver transplants performed by its leading surgeons, the department has extensive experience in living-donor, split-liver, pediatric, and multi-organ transplantation. Its innovative International Multidisciplinary Telemedicine Platform (iMDT) enables collaboration with leading medical institutions around the world, allowing patients to benefit from global expertise and advanced treatment strategies. Through its commitment to clinical excellence, innovation, and patient-centered care, the department continues to attract patients from across China and internationally.